CN1293569A - 神经病症的新疗法 - Google Patents
神经病症的新疗法 Download PDFInfo
- Publication number
- CN1293569A CN1293569A CN99804010A CN99804010A CN1293569A CN 1293569 A CN1293569 A CN 1293569A CN 99804010 A CN99804010 A CN 99804010A CN 99804010 A CN99804010 A CN 99804010A CN 1293569 A CN1293569 A CN 1293569A
- Authority
- CN
- China
- Prior art keywords
- reboxetine
- treatment
- patient
- disease
- ocd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Mobile Radio Communication Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (7)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8163298P | 1998-04-13 | 1998-04-13 | |
US60/081,632 | 1998-04-13 | ||
ITMI98A00087 | 1998-04-23 | ||
IT98MI000870 IT1305322B1 (it) | 1998-04-23 | 1998-04-23 | Uso di reboxetina per il trattamento di disturbi nervosi |
ITMI98A000870 | 1998-04-23 | ||
US8503398P | 1998-05-11 | 1998-05-11 | |
US60/085,033 | 1998-05-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1293569A true CN1293569A (zh) | 2001-05-02 |
CN1197569C CN1197569C (zh) | 2005-04-20 |
Family
ID=11379879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB99804010XA Expired - Fee Related CN1197569C (zh) | 1998-04-13 | 1999-04-02 | 神经病症的新疗法 |
Country Status (25)
Country | Link |
---|---|
US (1) | US6391876B1 (zh) |
EP (1) | EP1071418B1 (zh) |
JP (1) | JP2002511408A (zh) |
KR (1) | KR100555279B1 (zh) |
CN (1) | CN1197569C (zh) |
AT (1) | ATE277617T1 (zh) |
AU (1) | AU755612B2 (zh) |
BR (1) | BR9909476A (zh) |
CA (1) | CA2320722A1 (zh) |
DE (1) | DE69920679T2 (zh) |
DK (1) | DK1071418T3 (zh) |
EA (1) | EA003546B1 (zh) |
ES (1) | ES2228035T3 (zh) |
HU (1) | HUP0101748A3 (zh) |
IL (1) | IL138887A0 (zh) |
IT (1) | IT1305322B1 (zh) |
NO (1) | NO20005131D0 (zh) |
NZ (1) | NZ507693A (zh) |
PL (1) | PL194039B1 (zh) |
PT (1) | PT1071418E (zh) |
SI (1) | SI1071418T1 (zh) |
SK (1) | SK14482000A3 (zh) |
TR (1) | TR200002970T2 (zh) |
WO (1) | WO1999052518A2 (zh) |
ZA (1) | ZA200004480B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500827B2 (en) * | 1998-05-08 | 2002-12-31 | Pharmacia & Upjohn Company | Drug combinations |
EP1500395B1 (en) * | 1999-07-01 | 2006-03-08 | Pharmacia & Upjohn Company LLC | Reboxetine for treating fibromyalgia and other somatoform disorders |
PT1632234E (pt) | 1999-07-01 | 2007-07-09 | Pharmacia & Upjohn Co Llc | (s,s)-reboxetina para o tratamento da síndrome de fadiga crónica |
CA2426069A1 (en) * | 2000-11-15 | 2002-05-23 | David Michelson | Treatment of anxiety disorders |
BR0311878A (pt) * | 2002-06-17 | 2005-04-05 | Pharmacia Italia Spa | Sais farmacêuticos de reboxetina |
US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
GB8419683D0 (en) | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
GB2167407B (en) * | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
EP0919234A3 (en) | 1997-10-17 | 1999-08-25 | Eli Lilly And Company | Potentiation of pharmaceuticals by moxonidine |
-
1998
- 1998-04-23 IT IT98MI000870 patent/IT1305322B1/it active
-
1999
- 1999-04-02 BR BR9909476-2A patent/BR9909476A/pt not_active Application Discontinuation
- 1999-04-02 AT AT99918423T patent/ATE277617T1/de not_active IP Right Cessation
- 1999-04-02 SI SI9930684T patent/SI1071418T1/xx unknown
- 1999-04-02 PT PT99918423T patent/PT1071418E/pt unknown
- 1999-04-02 EA EA200001058A patent/EA003546B1/ru not_active IP Right Cessation
- 1999-04-02 NZ NZ507693A patent/NZ507693A/en unknown
- 1999-04-02 CA CA002320722A patent/CA2320722A1/en not_active Abandoned
- 1999-04-02 HU HU0101748A patent/HUP0101748A3/hu active IP Right Revival
- 1999-04-02 KR KR1020007011336A patent/KR100555279B1/ko not_active IP Right Cessation
- 1999-04-02 ES ES99918423T patent/ES2228035T3/es not_active Expired - Lifetime
- 1999-04-02 TR TR2000/02970T patent/TR200002970T2/xx unknown
- 1999-04-02 SK SK1448-2000A patent/SK14482000A3/sk unknown
- 1999-04-02 DK DK99918423T patent/DK1071418T3/da active
- 1999-04-02 US US09/673,768 patent/US6391876B1/en not_active Expired - Fee Related
- 1999-04-02 WO PCT/US1999/004288 patent/WO1999052518A2/en active IP Right Grant
- 1999-04-02 PL PL99346294A patent/PL194039B1/pl unknown
- 1999-04-02 CN CNB99804010XA patent/CN1197569C/zh not_active Expired - Fee Related
- 1999-04-02 JP JP2000543128A patent/JP2002511408A/ja active Pending
- 1999-04-02 AU AU36351/99A patent/AU755612B2/en not_active Ceased
- 1999-04-02 EP EP99918423A patent/EP1071418B1/en not_active Expired - Lifetime
- 1999-04-02 IL IL13888799A patent/IL138887A0/xx not_active IP Right Cessation
- 1999-04-02 DE DE69920679T patent/DE69920679T2/de not_active Expired - Fee Related
-
2000
- 2000-08-29 ZA ZA200004480A patent/ZA200004480B/en unknown
- 2000-10-12 NO NO20005131A patent/NO20005131D0/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gorelick et al. | Agents in development for the management of cocaine abuse | |
EP2248524A2 (en) | Preventives/remedies for stress urinary incontinence and method of screening the same | |
AU2021200697A1 (en) | Use of pridopidine for the treatment of anxiety and depression | |
US5447948A (en) | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia | |
CN110996946A (zh) | 用于治疗创伤后应激障碍的制剂 | |
CN1301164A (zh) | 神经病症的新疗法 | |
CN1197569C (zh) | 神经病症的新疗法 | |
CN1300217A (zh) | 瑞波西汀与吲哚洛尔的新的药物组合 | |
US6284771B1 (en) | Method for treating schizophrenia | |
EP4091607A1 (en) | Methods for treating central nervous system disorders with muscarinic receptor activator xanomeline and antipsychotics | |
WO2022246405A1 (en) | Methods for treating central nervous system disorders with muscarinic receptor activation and antipsychotics | |
US20240050427A1 (en) | Treatments for obsessive compulsive disorder | |
WO2008098245A2 (en) | Nmda receptor modulation and treatments for addictive behavior | |
Bai et al. | Psychopharmacotherapy in Patients with Tics and Other Motor Disorders | |
AU2018258970A1 (en) | Idalopirdine-based combinatorial therapies of Alzheimer's disease | |
AU2020298758A1 (en) | Therapeutic interactions of leucomethylthioninium | |
MXPA00010025A (en) | New treatments for nervous disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Priority number Correct: MI98A000870 False: MI98A00087 Number: 18 Page: 109 Volume: 17 |
|
CI02 | Correction of invention patent application |
Correction item: Priority number Correct: MI98A000870 False: MI98A00087 Number: 18 Page: The title page Volume: 17 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: NUMBER OF PRIORITY; FROM: MI98A 00087 TO: MI 98A 000870 |
|
ERR | Gazette correction |
Free format text: CORRECT: NUMBER OF PRIORITY; FROM: MI98A 00087 TO: MI 98A 000870 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: NUMBER OF PRIORITY; FROM: MI98A 00087 TO: MI 98A 000870 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1036216 Country of ref document: HK |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |